Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06045338 · ClinicalTrials.gov registry record · NA

Mind Body Intervention for Long COVID-19

A NA study of Long COVID and Post Acute Sequelae of COVID-19, sponsored by Beth Israel Deaconess Medical Center.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06045338 is a NA study of Long COVID and Post Acute Sequelae of COVID-19 that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 180 participants, below the 2,185-participant average among 50 other Long COVID trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06045338, a NA study of Long COVID and Post Acute Sequelae of COVID-19, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to usual care and an active control (second mind body intervention). The investigators will secondarily investigate whether the intervention alleviates individual somatic complaints and improves daily functioning, relative to usual care and the active control

Interventions

  • BEHAVIORAL Mind Body Intervention #1

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-11-09
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT06045338

The ClinicalTrials.gov registry entry for NCT06045338 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,185-participant average among 50 other Long COVID trials with a reported enrollment target (92% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Long COVID appearing as the primary indexed condition, and to 1 intervention - of which Mind Body Intervention #1 is the first listed.

NCT06045338 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06045338 about?

NCT06045338 is a clinical study titled "Mind Body Intervention for Long COVID-19". The goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participants as compared to u...

What is the current status of trial NCT06045338?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-11-09. Estimated completion is 2026-12.

What conditions does trial NCT06045338 study?

This clinical trial studies the following conditions: Long COVID, Post Acute Sequelae of COVID-19, COVID Long-Haul.

What interventions are being tested in trial NCT06045338?

The interventions under investigation include: Mind Body Intervention #1 (BEHAVIORAL).

Who is sponsoring clinical trial NCT06045338?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06045338 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.